Cargando…

Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay

BACKGROUND: Non-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM disease may clinically present with one of the four symptoms consistent with tuberculosis (TB). We describe the prevalence of NTM and Mycobacterium...

Descripción completa

Detalles Bibliográficos
Autores principales: Agizew, Tefera, Basotli, Joyce, Alexander, Heather, Boyd, Rosanna, Letsibogo, Gaoraelwe, Auld, Andrew, Nyirenda, Sambayawo, Tedla, Zegabriel, Mathoma, Anikie, Mathebula, Unami, Pals, Sherri, Date, Anand, Finlay, Alyssa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741233/
https://www.ncbi.nlm.nih.gov/pubmed/29272273
http://dx.doi.org/10.1371/journal.pone.0189981
_version_ 1783288164155129856
author Agizew, Tefera
Basotli, Joyce
Alexander, Heather
Boyd, Rosanna
Letsibogo, Gaoraelwe
Auld, Andrew
Nyirenda, Sambayawo
Tedla, Zegabriel
Mathoma, Anikie
Mathebula, Unami
Pals, Sherri
Date, Anand
Finlay, Alyssa
author_facet Agizew, Tefera
Basotli, Joyce
Alexander, Heather
Boyd, Rosanna
Letsibogo, Gaoraelwe
Auld, Andrew
Nyirenda, Sambayawo
Tedla, Zegabriel
Mathoma, Anikie
Mathebula, Unami
Pals, Sherri
Date, Anand
Finlay, Alyssa
author_sort Agizew, Tefera
collection PubMed
description BACKGROUND: Non-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM disease may clinically present with one of the four symptoms consistent with tuberculosis (TB). We describe the prevalence of NTM and Mycobacterium tuberculosis complex (MTBC) isolated among PLHIV who presented for HIV care and treatment. METHODS: All PLHIV patients presenting for HIV care and treatment services at 22 clinical sites in Botswana were offered screening for TB and were recruited. Patients who had ≥1 TB symptom were asked to submit sputa for Xpert MTB/RIF and culture. Culture growth was identified as NTM and MTBC using the SD-Bioline TB Ag MPT64 Kit and Ziehl Neelsen microscopy. NTM and MTBC isolates underwent species identification by the Hain GenoType CM and AS line probe assays. RESULTS: Among 16, 259 PLHIV enrolled 3068 screened positive for at least one TB symptom. Of these, 1940 submitted ≥1 sputum specimen, 427 (22%) patients had ≥1 positive-culture result identified phenotypically for mycobacterial growth. Of these 247 and 180 patients were identified as having isolates were NTM and MTBC, respectively. Of the 247 patients identified with isolates containing NTM; 19 were later excluded as not having NTM based on additional genotypic testing. Among the remaining 408 patients 228 (56%, 95% confidence interval, 46–66%) with NTM. M. intracellulare was the most common isolated (47.8%). Other NTMs commonly associated with pulmonary disease included M. malmoense (3.9%), M. avium (2.2%), M. abscessus (0.9%) and M. kansasii (0.4%). After excluding NTM isolates that were non-speciated and M. gordonae 154 (67.5%) of the NTM isolates were potential pathogens. CONCLUSIONS: In the setting of HIV care and treatment, over-half (56%) of a positive sputum culture among PLHIV with TB symptoms was NTM. Though we were not able to distinguish in our study NTM disease and colonization, the study suggests culture and species identification for PLHIV presenting with TB symptoms remains important to facilitate NTM diagnosis and hasten time to appropriate treatment.
format Online
Article
Text
id pubmed-5741233
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57412332018-01-10 Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay Agizew, Tefera Basotli, Joyce Alexander, Heather Boyd, Rosanna Letsibogo, Gaoraelwe Auld, Andrew Nyirenda, Sambayawo Tedla, Zegabriel Mathoma, Anikie Mathebula, Unami Pals, Sherri Date, Anand Finlay, Alyssa PLoS One Research Article BACKGROUND: Non-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM disease may clinically present with one of the four symptoms consistent with tuberculosis (TB). We describe the prevalence of NTM and Mycobacterium tuberculosis complex (MTBC) isolated among PLHIV who presented for HIV care and treatment. METHODS: All PLHIV patients presenting for HIV care and treatment services at 22 clinical sites in Botswana were offered screening for TB and were recruited. Patients who had ≥1 TB symptom were asked to submit sputa for Xpert MTB/RIF and culture. Culture growth was identified as NTM and MTBC using the SD-Bioline TB Ag MPT64 Kit and Ziehl Neelsen microscopy. NTM and MTBC isolates underwent species identification by the Hain GenoType CM and AS line probe assays. RESULTS: Among 16, 259 PLHIV enrolled 3068 screened positive for at least one TB symptom. Of these, 1940 submitted ≥1 sputum specimen, 427 (22%) patients had ≥1 positive-culture result identified phenotypically for mycobacterial growth. Of these 247 and 180 patients were identified as having isolates were NTM and MTBC, respectively. Of the 247 patients identified with isolates containing NTM; 19 were later excluded as not having NTM based on additional genotypic testing. Among the remaining 408 patients 228 (56%, 95% confidence interval, 46–66%) with NTM. M. intracellulare was the most common isolated (47.8%). Other NTMs commonly associated with pulmonary disease included M. malmoense (3.9%), M. avium (2.2%), M. abscessus (0.9%) and M. kansasii (0.4%). After excluding NTM isolates that were non-speciated and M. gordonae 154 (67.5%) of the NTM isolates were potential pathogens. CONCLUSIONS: In the setting of HIV care and treatment, over-half (56%) of a positive sputum culture among PLHIV with TB symptoms was NTM. Though we were not able to distinguish in our study NTM disease and colonization, the study suggests culture and species identification for PLHIV presenting with TB symptoms remains important to facilitate NTM diagnosis and hasten time to appropriate treatment. Public Library of Science 2017-12-22 /pmc/articles/PMC5741233/ /pubmed/29272273 http://dx.doi.org/10.1371/journal.pone.0189981 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Agizew, Tefera
Basotli, Joyce
Alexander, Heather
Boyd, Rosanna
Letsibogo, Gaoraelwe
Auld, Andrew
Nyirenda, Sambayawo
Tedla, Zegabriel
Mathoma, Anikie
Mathebula, Unami
Pals, Sherri
Date, Anand
Finlay, Alyssa
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
title Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
title_full Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
title_fullStr Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
title_full_unstemmed Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
title_short Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
title_sort higher-than-expected prevalence of non-tuberculous mycobacteria in hiv setting in botswana: implications for diagnostic algorithms using xpert mtb/rif assay
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741233/
https://www.ncbi.nlm.nih.gov/pubmed/29272273
http://dx.doi.org/10.1371/journal.pone.0189981
work_keys_str_mv AT agizewtefera higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT basotlijoyce higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT alexanderheather higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT boydrosanna higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT letsibogogaoraelwe higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT auldandrew higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT nyirendasambayawo higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT tedlazegabriel higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT mathomaanikie higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT mathebulaunami higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT palssherri higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT dateanand higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay
AT finlayalyssa higherthanexpectedprevalenceofnontuberculousmycobacteriainhivsettinginbotswanaimplicationsfordiagnosticalgorithmsusingxpertmtbrifassay